Vitamin B13 cannot be proven safe, says EFSA

By Shane Starling

- Last updated on GMT

Related tags: European food safety authority

The European Food Safety Authority (EFSA) has found 10 forms of orotic acid, or vitamin B13, cannot be deemed safe, after conducting a review.

EFSA’s Panel on Food Additives and Nutrient Sources added to Food (ANS) found the 10 orotic acid cations, required for DNA and RNA synthesis, was potentially hazardous, with one animal study demonstrating a tumour-promoting effect.

“The Panel concludes that in the light of the tumour-promoting effect of orotic acid in animal experimentation, the small margin of safety to this effect from foreseeable exposure, and the absence of any relevant studies on genotoxicity and of any developmental studies, the use of orotate … at the proposed levels of use is of safety concern,”​ the ANS stated.

The ANS was asked to provide opinion on the safety and bioavailability of magnesium orotate, zinc orotate, calcium orotate, chromium orotate, copper orotate, iron orotate, manganese orotate, potassium orotate, sodium orotate and choline orotate in food supplements.

The safety of the cations themselves, was not considered by the ANS.

It noted that proposed usage levels by the petitioners – Germany-based Pharmorgana and Lyomark and the UK Health Food Manufacturers’ Association (HFMA) – were provided for forms other than choline and sodium came in between 1.8-6206mg/day.

“For consumers who would consume several nutrients with orotates as source, the total anticipated combined exposure would amount over 11g/day,”​ ANS said.

“Little documentation on the bioavailability of the mineral salts of orotic acid has been submitted, but one study reveals that the bioavailability of zinc from zinc orotate is comparable to that of zinc from another organic source, as well as an inorganic salt,”​ it said, noting this would likely apply to the bioavailability of the other salts.

“No data were submitted on reproductive and developmental toxicity and only irrelevant data on genotoxicity.”

It highlighted a study that showed tumour formation in rats receiving repeated dosage of orotic acid at levels between 0.5 and two per cent of their total dietary intake.

It thus established a No Observed Adverse Effect Level (NOAEL) of 50mg/kg body weight/day, while the Lowest Observed Effect Level at 100 mg/kg bw/day.

Orotic acid occurs in cow’s milk but at higher levels in goat’s and sheep’s milk and has been found at levels of 15-118 mg/L in infant formula.

The opinion can be found here​.

Related news

Related products

show more

Divi’s extensive Vitamin D2 and D3 portfolio

Divi’s extensive Vitamin D2 and D3 portfolio

Divis Nutraceuticals | 18-May-2021 | Product Brochure

As an expert in the formulation of fat-soluble vitamins, Divi's offers a large portfolio of vitamins D2 and D3 in the form of spray-dried powders,...

Innovation: L-Vital C®, true liposomal vitamin C

Innovation: L-Vital C®, true liposomal vitamin C

CAPSULARIS | 14-Apr-2021 | Product Brochure

Did you know that the liquid liposomal vitamin is the form of vitamin C that is best utilized by the body? Liposomes need aqueous solutions to live and...

HydroCurc + Fe = Smart Formula

HydroCurc + Fe = Smart Formula

Gencor | 02-Mar-2021 | Clinical Study

Iron deficiency is the most prevalent micronutrient deficiency in the world and can have impacts on physical and mental health. A critical micronutrient...

Sustainable sources for supplement ingredients

Sustainable sources for supplement ingredients

TSI Group LTD – Healthy Begins Here | 01-Mar-2021 | Infographic

Studies around the world show that consumers are increasingly attracted to brands that have similar values to their own. Sustainable or “green” practices...

Related suppliers

Follow us


View more